Signal2026-08-03
ClinicalTrials.gov

[NA] Camrelizumab, Pegaspargase and Apatinib With Radiation Therapy for Stage IE/IIE ENKTL

Part of

Emerging Clinical Immunotherapy And Treatment Trials